Inventor · disambiguated record
Frederick H. Hausheer
Also filed as: HAUSHEER FREDERICK · HAUSHEER FREDERICK H · HAUSHEER FREDERICK HERMAN
87 granted patents·13 pending applications·5,684 citations·filing 1990–2022
99Inventor score
Files withBIONUMERIK PHARMACEUTICALS INC76HAUSHEER FREDERICK H8CHEN XINGHAI3LANTERN PHARMA INC2STERLING DRUG INC2
Top patents by PatentIndex Score
100 records- 0198US5677439AOligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleotide analoguesSANOFI SA·Filed 1995·Granted Oct 14, 1997·1.2k cites·58 claims
- 0297US5726181AFormulations and compositions of poorly water soluble camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1995·Granted Mar 10, 1998·147 cites·21 claims
- 0397US5567810ANuclease resistant compoundsSTERLING DRUG INC·Filed 1995·Granted Oct 22, 1996·871 cites·3 claims
- 0497US5214134AProcess of linking nucleosides with a siloxane bridgeSTERLING WINTHROP INC·Filed 1990·Granted May 25, 1993·1.3k cites·24 claims
- 0596US5919816AFormulations and methods of reducing toxicity of antineoplastic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Jul 6, 1999·112 cites·15 claims
- 0695US5245022AExonuclease resistant terminally substituted oligonucleotidesSTERLING DRUG INC·Filed 1990·Granted Sep 14, 1993·890 cites·26 claims
- 0792US8026227B2Chemoprotective methods and compositionsBIONUMERIK PHARMACEUTICALS INC·Filed 2006·Granted Sep 27, 2011·21 cites·159 claims
- 0892US7759488B2Monoazole ligand platinum analogsBIONUMERIK PHARMACEUTICALS INC·Filed 2006·Granted Jul 20, 2010·30 cites·6 claims
- 0991US5859022AFormulations and compositions of poorly water soluble camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Jan 12, 1999·65 cites·25 claims
- 1090US8143236B2Chemoprotective methodsHAUSHEER FREDERICK H·Filed 2008·Granted Mar 27, 2012·8 cites·14 claims
- 1187US7687496B2C7-substituted camptothecin analogsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Mar 30, 2010·6 cites·6 claims
- 1287US5789000ASterile aqueous parenteral formulations of cis-diammine dichloro platinumBIONUMERIK PHARMACEUTICALS INC·Filed 1994·Granted Aug 4, 1998·44 cites·3 claims
- 1386US9320760B2Compositions and methods of use of compounds to increase cancer patient survival timeHAUSHEER FREDERICK H·Filed 2008·Granted Apr 26, 2016·4 cites·18 claims
- 1486US6596320B1Method for treating cancer having greater efficacy and reduced adverse effectsBIONUMERIK PHARMACEUTICALS INC·Filed 2002·Granted Jul 22, 2003·19 cites·9 claims
- 1586US6057303AHighly lipophilic Camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1998·Granted May 2, 2000·35 cites·10 claims
- 1685US9023805B2Increasing cancer patient survival time by administration of dithio-containing compoundsHAUSHEER FREDERICK H·Filed 2010·Granted May 5, 2015·4 cites·35 claims
- 1784US5902610AFormulations and methods of use of 2,2'-dithio-bis-ethane sulfonateBIONUMERIK PHARMACEUTICALS INC·Filed 1995·Granted May 11, 1999·41 cites·20 claims
- 1884US5447936ALactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereofBIONUMERIK PHARMACEUTICALS INC·Filed 1993·Granted Sep 5, 1995·54 cites·22 claims
- 1982US5859023AFormulations and compositions of poorly water soluble camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Jan 12, 1999·36 cites·13 claims
- 2082US5468754A11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereofBIONUMERIK PHARMACEUTICALS INC·Filed 1994·Granted Nov 21, 1995·52 cites·36 claims
- 2181US5910491AHighly lipophilic camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Jun 8, 1999·42 cites·14 claims
- 2280US6066645AFormulations and methods of reducing toxicity of antineoplastic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 1999·Granted May 23, 2000·25 cites·20 claims
- 2379US7235589B2Method of treating patients undergoing kidney dialysisBIO NUMERIK PHARMACEUTICALS IN·Filed 2004·Granted Jun 26, 2007·17 cites·3 claims
- 2479US6057361AFormulations and methods of reducing toxicity of antineoplastic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 1999·Granted May 2, 2000·23 cites·20 claims
- 2578US6225295B1Method of treating acetaminophen overdoseFiled 2000·Granted May 1, 2001·8 cites·4 claims
- 2678US6066668AFormulations and methods of reducing toxicity of antineoplastic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 1999·Granted May 23, 2000·22 cites·20 claims
- 2778US5880133APharmaceutical formulations of highly lipophilic camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1996·Granted Mar 9, 1999·31 cites·12 claims
- 2878US5866169AFormulations and methods of use of 2,2'-dithio-bis-ethane sulfonateBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Feb 2, 1999·33 cites·3 claims
- 2977US5674874ALactone stable formulation of 7-ethyl 10-hydroxy camptothecin and methods for uses thereofBIONUMERIK PHARMACEUTICALS INC·Filed 1995·Granted Oct 7, 1997·35 cites·9 claims
- 3075US5958937APharmaceutical formulations of poorly water soluble camptothecin analogues and NMPBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Sep 28, 1999·24 cites·25 claims
- 3173US11471431B2Increasing cancer patient survival time by administration of dithio-containing compoundsLANTERN PHARMA INC·Filed 2015·Granted Oct 18, 2022·1 cites·8 claims
- 3273US7829539B2Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Nov 9, 2010·0 cites·1 claims
- 3373US7829117B2Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Nov 9, 2010·0 cites·1 claims
- 3473US7829541B2Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Nov 9, 2010·0 cites·1 claims
- 3573US7829538B2Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Nov 9, 2010·0 cites·1 claims
- 3673US7829540B2Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 2007·Granted Nov 9, 2010·0 cites·1 claims
- 3773US5900419AFormulations and compositions of poorly water soluble camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted May 4, 1999·23 cites·16 claims
- 3872US7238823B2Platinum complexes with mononitrile-containing ligandsBIONUMERIK PHARMACEUTICALS INC·Filed 2006·Granted Jul 3, 2007·2 cites·65 claims
- 3972US5866617AFormulations and methods of use 2,2'-dithio-bis-esthane sulfonateBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Feb 2, 1999·24 cites·6 claims
- 4070US7176192B2Method for treating patients for radiation exposureBIONUMERIK PHARMACEUTICALS INC·Filed 2001·Granted Feb 13, 2007·1 cites·21 claims
- 4170US6028078AHighly lipophilic camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1998·Granted Feb 22, 2000·23 cites·13 claims
- 4269US8710095B2Drugs for prophylaxis or mitigation of taxane-induced neurotoxicityHAUSHEER FREDERICK H·Filed 2002·Granted Apr 29, 2014·4 cites·51 claims
- 4369US6525037B1Method of treating atherosclerosis and complications resulting therefromBIONUMERIK PHARMACEUTICALS INC·Filed 2000·Granted Feb 25, 2003·1 cites·4 claims
- 4469US2023210794A1Increasing Cancer Patient Survival Time by Administration of Dithio-Containing CompoundsLANTERN PHARMA INC·Filed 2022·Application pending·0 cites
- 4568US6291441B1Method of treating inflammatory bowel disordersFiled 2000·Granted Sep 18, 2001·1 cites·4 claims
- 4668US6046159AFormulations and methods of reducing toxicity of antineoplastic agentsBIONUMERIK PHARMACEUTICALS INC·Filed 1999·Granted Apr 4, 2000·13 cites·23 claims
- 4768US6037336AReducing toxic effects of carboplatin using dithioethersBIONUMERIK PHARMACEUTICALS INC·Filed 1997·Granted Mar 14, 2000·15 cites·11 claims
- 4867US7569606B2Platinum complexes with mononitrile-containing ligandsBIONUMERIK PHARMACEUTICALS INC·Filed 2006·Granted Aug 4, 2009·1 cites·6 claims
- 4964US10413538B2Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancerBIONUMERIK PHARMACEUTICALS INC·Filed 2014·Granted Sep 17, 2019·0 cites·7 claims
- 5064US6169080B1Highly lipophilic camptothecin derivativesBIONUMERIK PHARMACEUTICALS INC·Filed 1998·Granted Jan 2, 2001·12 cites·10 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Frederick H. Hausheer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →